|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/32 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3319995 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16741212.1 |
| Date of filing the European patent application | 2016-07-06 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation | 2019-07-10 |
| (86) | Number | PCT/US2016/041184 |
| Date | 2016-07-06 |
| (87) | Number | WO 2017/007846 |
| Date | 2017-01-12 |
| (30) | Number | Date | Country code |
| 201562189610 P | 2015-07-07 | US |
| (72) |
PHILLIPS, Gail Lewis, US
SAMPATH, Deepak, US
WERTZ, Ingrid, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sudėtinis gydymas anti-HER-2 antikūno-vaisto konjugatu ir Bcl-2 inhibitoriumi |
| COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 10 | 231.00 EUR |
| 2026-07-06 |